Novartis Pharma and Folia Health Collaborate on Groundbreaking App Study for Real-World Assessment of IgA Nephropathy Patient Experiences

Folia Health and Novartis Collaborate on Groundbreaking IgA Nephropathy Study Boston, MA, March 13, 2025 – Folia Health, a leading digital health company, and Novartis Pharmaceuticals, Inc., a global healthcare leader, have announced an innovative collaboration to advance the understanding of IgA nephropathy (IgAN) through an at-home observational real-world evidence initiative. This collaboration leverages Folia’s…

Read More

NFL’s First Pharmaceutical Partner: Novartis – An Exciting New Team-Up in Healthcare!

The NFL’s New Pharmaceutical Partner: Novartis In an unprecedented move for the National Football League (NFL), a league source revealed to Reuters that the organization has signed its first-ever pharmaceutical partner in a multi-year deal with Novartis, a Switzerland-based firm. This collaboration marks a significant shift in the NFL’s approach to player health and wellness….

Read More

Precigen to Release Full-Year 2024 Financial Results and Provide Business Updates on March 19th

Precigen’s Full Year 2024 Financial Results and Business Updates On March 13, 2025, Precigen, Inc., a leading biopharmaceutical company focusing on the development of advanced gene and cell therapies, made an important announcement. The company revealed that it will be releasing its full financial results for the year 2024, in addition to providing business updates,…

Read More

Argentina’s Heartfelt Plea to Interpol: Unraveling the Emotional Tangle of the Libra MemeCoin Scandal

Nemesis Darknet Marketplace: US Sanctions 49 Crypto Wallets In a significant move against illegal activities on the dark web, the United States Department of the Treasury’s Office of Foreign Assets Control (OFAC) announced the sanctions against 49 cryptocurrency wallets associated with the Nemesis darknet marketplace. This marketplace was known for selling illicit goods, including drugs,…

Read More

Equilend Secures Minority Investment from BNY Mellon: A Game-Changing Partnership in Fintech

EquiLend Secures Minority Investment from The Bank of New York Mellon New York, NY – March 13, 2025 EquiLend, a pioneering provider of technology, data, and analytics solutions for the securities finance industry, recently announced a strategic investment from an affiliate of The Bank of New York Mellon Corporation (BNY). This investment marks a significant…

Read More